Investseekers points to Fierce Pharma's refreshed chart showing how the two oral obesity pill launches from Novo Nordisk and Eli Lilly are tracking over time.
Recap by typeshit. Post by @investseekers on X.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
The writer argues tirzepatide does more than curb eating, pointing to its effects on appetite, fullness and blood sugar. A general explainer.
A blog from Grace weighs the evidence behind peptide therapy, covering both possible benefits and the risks. Thin on specifics in the shared post.
Loading…